A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer

NCT00354562 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer
Non-Small Cell Lung Cancer

Interventions

DRUG: ABT-751
DRUG: Placebo
DRUG: Docetaxel

Sponsor

Abbott